Cited by 505Hormonal Regulation and HypertensionRenin-Angiotensin System StudiesPotassium and Related Disorders

The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.

Cardiovascular Complications Associated With Primary Aldosteronism: A Controlled Cross-Sectional Study

Savard, Sébastien, Amar, Laurence, Plouin, Pierre-François, Steichen, Olivier·2013·Hypertension

Open this paper in CoChat — free account

Abstract

A higher risk of cardiovascular events has been reported in patients with primary aldosteronism (PA) than in otherwise similar patients with essential hypertension (EH). However, the evidence is limited by small sample size and potential confounding factors. We, therefore, compared the prevalence of cardiovascular events in 459 patients with PA diagnosed in our hypertension unit from 2001 to 2006 and 1290 controls with EH. PA cases and EH controls were individually matched for sex, age (±2 years), and office systolic blood pressure (±10 mm Hg). Patients with PA and EH differed significantly in duration of hypertension, serum potassium, plasma aldosterone and plasma renin concentrations, aldosterone-to-renin ratio, and urinary aldosterone concentration (P<0.001 for all comparisons). The prevalence of electrocardiographic and echocardiographic left ventricular hypertrophy was about twice higher in patients with PA even after adjustment for hypertension duration. PA patients also had a significantly higher prevalence of coronary artery disease (adjusted odds ratio, 1.9), nonfatal myocardial infarction (adjusted odds ratio, 2.6), heart failure (adjusted odds ratio, 2.9), and atrial fibrillation (adjusted odds ratio, 5.0). The risks associated with PA were similar across levels of serum potassium and plasma aldosterone. To conclude, patients with PA are more likely to have had a cardiovascular complication at diagnosis than otherwise similar patients with EH. Target organ damage and complications disproportionate to blood pressure should be considered as an additional argument for suspecting PA in a given individual and possibly for broadening the scope of screening at the population level.

Integrity signals

Registry

Crossref · 10.1161/hypertensionaha.113.01060

Cites

50 of 50 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Recommendations for Chamber Quantification: A Report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, Developed in Conjunction with the European Association of Echocardiography, a Branch of the European Society of Cardiology
Lang, R. M., Bierig, M., Devereux, R. B., Flachskampf, F. A., Foster, E., Pellikka, P. A., Picard, M. H., Roman, M. J., Seward, J., Shanewise, J. S., et al. (2005) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2005.10.005 · Cited by 11,318
Heart Disease and Stroke Statistics—2012 Update: A Report From the American Heart Association
Writing Group Members, Roger, V. L., Go, A. S., Lloyd-Jones, D. M., Benjamin, E. J., Berry, J. D., Borden, W. B., Bravata, D. M., Dai, S., Ford, E. S., et al. (2012) · Circulation · doi:10.1161/cir.0b013e31823ac046 · Cited by 7,333
Universal Definition of Myocardial Infarction
Thygesen, K. A., Alpert, J. S., White, H. D., TASK FORCE MEMBERS: Chairpersons: Kristian Thygesen (Denmark), J. S. A. (., Biomarker Group: Allan S. Jaffe, C. (., ECG Group: Bernard Chaitman, C.-O. (., Imaging Group: Richard Underwood, C. (., Intervention Group: Jean-Pierre Bassand, C.-O. (., Mendis, S., Implementation Group: Lars C. Wallentin Coordinator (Sweden), F. F.-A. (., et al. (2007) · Circulation · doi:10.1161/circulationaha.107.187397 · Cited by 4,422
Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction. Universal definition of myocardial infarction
Thygesen, K. A. (2007) · Circulation · Cited by 3,126
ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society
Fuster, V., Rydén, L. E., Cannom, D. S., Crijns, H. J., Curtis, A. B., Ellenbogen, K. A., Halperin, J. L., Le Heuzey, J.-Y., Kay, G. N., Lowe, J. E., et al. (2006) · Circulation · doi:10.1161/circulationaha.106.177292 · Cited by 2,805
The ventricular complex in left ventricular hypertrophy as obtained by unipolar precordial and limb leads
Sokolow, M., & Lyon, T. P. (1949) · American Heart Journal · doi:10.1016/0002-8703(49)90562-1 · Cited by 1,990
Untitled work
(2000) · Journal of the American Society of Nephrology · Cited by 1,718
Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism
Milliez, P., Girerd, X. J., Plouin, P., Blacher, J., Safar, M. E., & Mourad, J. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.01.015 · Cited by 1,541
Self-citation
Effect of growth on variability of left ventricular mass: Assessment of allometric signals in adults and children and their capacity to predict cardiovascular risk
SIMONE, G. D., Devereux, R. B., Daniels, S. R., Koren, M. J., Meyer, R. A., & Laragh, J. H. (1995) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(94)00540-7 · Cited by 900
Oxford textbook of clinical nephrology
Cameron, S. M. (2013) · Oxford University Press eBooks · Cited by 717

Show all 50 references

Sorted by citations

Items 301–400 of 503

Acid‐sensing ion channel 1a deficiency drives endocrine hypertension in male mice
Garcia, S. M., Tuineau, M. N., DeLeon, X. A., Detweiler, N. D., Tamang, S., Kanagy, N. L., Bosc, L. V. G., Resta, T. C., Naik, J. S., & Jernigan, N. L. (2025) · The Journal of Physiology · doi:10.1113/jp289258 · Cited by 6
Bypass of confirmatory tests for case detection of primary aldosteronism in leaner patients?
Stavropoulos, K., Imprialos, K. P., & Doumas, M. N. (2017) · Journal of Clinical Hypertension · doi:10.1111/jch.13039 · Cited by 6
Systolic heart failure in a patient with primary aldosteronism
Alvarez, C., & Mohan, V. (2018) · BMJ Case Reports · doi:10.1136/bcr-2018-225145 · Cited by 6
Taiwan mini-frontier of primary aldosteronism: Updating treatment and comorbidities detection
Chan, C., Chang, Y., Tsai, Y., Chen, Z., Wu, C.-Y., Huang, W., Yen, I., Wu, K.-H., Wu, V., Lin, Y., et al. (2021) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2021.03.032 · Cited by 6
Impact of Primary Aldosteronism in Resistant Hypertension
Stavropoulos, K., Imprialos, K. P., Patoulias, D., Katsimardou, A., & Doumas, M. N. (2022) · Current Hypertension Reports · doi:10.1007/s11906-022-01190-9 · Cited by 6
Rating the blood pressure outcome after adrenalectomy for unilateral primary aldosteronism
Steichen, O. (2017) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(17)30180-8 · Cited by 6
Self-citation
Primary aldosteronism long-term outcome: Medical versus surgical therapy
Schneider, H., Williams, T. A., Heinrich, D. A., Lechner, B., & Reincke, M. (2019) · Current Opinion in Endocrine and Metabolic Research · doi:10.1016/j.coemr.2019.08.008 · Cited by 6
Emerging Medical Therapies for Primary Aldosteronism
Vibhatavata, P., & Turcu, A. F. (2026) · Hypertension · doi:10.1161/hypertensionaha.126.26229 · Cited by 5
Modulation of Calcium Signaling on Demand to Decipher the Molecular Mechanisms of Primary Aldosteronism
Fedlaoui, B., Cosentino, T., Sayed, Z. R. A., Coelho, R. A., Giscos-Douriez, I., Faedda, N., Fayad, M., Hulot, J., Magnus, C. J., Sternson, S. M., et al. (2025) · Hypertension · doi:10.1161/hypertensionaha.124.23295 · Cited by 5
A narrative review of Hyporeninemic hypertension—an indicator for monogenic forms of hypertension
Mashmoushi, A. K., & Wolf, M. T. F. (2021) · Pediatric Medicine · doi:10.21037/pm-21-48 · Cited by 5
Indices of ACTH‐stimulated adrenal venous sampling as predictors of postsurgical outcomes in primary aldosteronism
Lee, S. H., Kim, J. W., Yoon, H., Kim, S. W., Kim, S. J., Lee, K. E., Lee, Y., Sung, T., Hong, S. J., Shin, C. S., et al. (2021) · Clinical Endocrinology · doi:10.1111/cen.14610 · Cited by 5
Clinical Characteristics of Target Organ Damage in Primary Aldosteronism with or without Metabolic Syndrome
Bu, X., Sun, F., Zhang, H., Liu, X., Zhao, Z., He, H., Li, Y., Yan, Z., & Zhu, Z. (2022) · Journal of Diabetes Research · doi:10.1155/2022/8932133 · Cited by 5
Follow-up care and assessment of comorbidities and complications in patients with primary aldosteronism: The clinical practice guideline of the Taiwan Society of aldosteronism
Pan, L.-H., Chen, Y.-Y., Pan, C., Hsu, C., Tseng, C., Yen, I., Chan, C., & Lin, L. (2023) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2023.08.010 · Cited by 5
Postoperative ACTH-stimulated aldosterone predicts biochemical outcome in primary aldosteronism
Brüdgam, D., Adolf, C., Schneider, H., Schwarzlmueller, P., Mueller, L., Handgriff, L., Bidlingmaier, M., Kunz, S. L., Zimmermann, P., Deniz, S., et al. (2023) · European Journal of Endocrinology · doi:10.1093/ejendo/lvad159 · Cited by 5
Suppressed Renin Status Is a Risk Factor for Cardiocerebrovascular Events in Bilateral Primary Aldosteronism Treated With Mineralocorticoid Receptor Antagonists
Jiang, Y., Zhou, L., Zhang, C., Su, T., Jiang, L., Zhou, W., Zhong, X., Wu, L., & Wang, W. (2024) · Endocrine Practice · doi:10.1016/j.eprac.2024.09.002 · Cited by 5
The association between aldosterone and lipid profiles in patients with primary aldosteronism
Liang, N., Rao, K.-R., Hu, M., Bao, R.-Y., Liu, J.-W., Lai, Z.-Q., Zhang, H., Zhang, H., Wu, M.-B., Zhang, X., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-92477-9 · Cited by 5
Role of Nox2 and p22phox in Persistent Postoperative Hypertension in Aldosterone-Producing Adenoma Patients after Adrenalectomy
Geng, X., Yan, L., Dong, J., Liang, Y. J., Deng, Y., Li, T., Luo, T., Lin, H., & Zhang, S. (2016) · International Journal of Endocrinology · doi:10.1155/2016/2395634 · Cited by 5
The Long-term Effect of Adrenal Arterial Embolization for Unilateral Primary Aldosteronism on Cardiorenovascular Protection, Blood Pressure, and the Endocrinological Profile
Kometani, M., Yoneda, T., Demura, M., Karashima, S., Mori, S., Oe, M., Sawamura, T., Okuda, R., Yamagishi, M., & Takeda, Y. (2016) · Internal Medicine · doi:10.2169/internalmedicine.55.5196 · Cited by 5
Atrial Fibrillation and Its Association with Endocrine Disorders.
Devidi, M., Buddam, A. R., Dacha, S., & Rao, D. S. (2014) · Europe PMC (PubMed Central) · doi:10.4022/jafib.959 · Cited by 5
Serum-soluble (pro)renin receptor concentration as a biomarker for organ damage in primary aldosteronism
Yamashita, K., Morimoto, S., Seki, Y., Watanabe, D., & Ichihara, A. (2019) · Hypertension Research · doi:10.1038/s41440-019-0312-9 · Cited by 5
Arterial stiffness evaluated by pulse wave velocity is not predictive of the improvement in hypertension after adrenal surgery for primary aldosteronism: A multicentre study from the French European Society of Hypertension Excellence Centres
Bouhanick, B., Amar, J., Amar, L., Gosse, P., Girerd, X. J., Reznik, Y., Mounier‐Véhier, C., Baguet, J.-P., Boutouyrie, P., Lepage, B., et al. (2018) · Archives of cardiovascular diseases · doi:10.1016/j.acvd.2018.01.004 · Cited by 5
Self-citation
Improvement of Cardiac Function by Laparoscopic Adrenalectomy in a Patient with Severe Heart Failure Attributable to Primary Aldosteronism
Sato, S., Kawasaki, Y., Ito, A., Morimoto, R., Shimada, S., Sato, T., Izumi, H., Kawamorita, N., Yamashita, S., Mitsuzuka, K., et al. (2019) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.248.31 · Cited by 5
Plasmacytoid Dendritic Cell Content Is Associated With Plasma Aldosterone Concentration in Patients With Primary Aldosteronism
Imiela, A. M., Mikolajczyk, T. P., Kołodziejczyk‐Kruk, S., Kądziela, J., Śpiewak, M., Januszewicz, M., Kabat, M., Sterliński, I., Wąs, M., Wróbel, A., et al. (2025) · American Journal of Hypertension · doi:10.1093/ajh/hpaf019 · Cited by 4
Somatic Mutations Associated with Aldosterone-Producing Adenomas (APAs)
Rahman, A. N. A., & Azizan, E. A. B. A. (2025) · Genes · doi:10.3390/genes16070778 · Cited by 5
Plasma galectin-3 concentrations in patients with primary aldosteronism
van den Berg, T. N. A., Meijers, W. C., Donders, A. R. T., van Herwaarden, A. E., Rongen, G. A. P. J. M., de Boer, R. A., Deinum, J., & Riksen, N. P. (2017) · Journal of Hypertension · doi:10.1097/hjh.0000000000001383 · Cited by 4
Effects of potassium supplementation on plasma aldosterone: a systematic review and meta-analysis in humans
McNally, R., Farukh, B., Chowienczyk, P., & Faconti, L. (2024) · Journal of Hypertension · doi:10.1097/hjh.0000000000003764 · Cited by 4
Issues in the Diagnosis and Treatment of Primary Aldosteronism
Burrello, J., Monticone, S., Buffolo, F., Tetti, M., Giraudo, G., Schiavone, D., Veglio, F., & Mulatero, P. (2015) · High Blood Pressure & Cardiovascular Prevention · doi:10.1007/s40292-015-0084-5 · Cited by 4
Positive association between KCNJ5 rs2604204 (A/C) polymorphism and plasma aldosterone levels, but also plasma renin and angiotensin I and II levels, in newly diagnosed hypertensive Chinese: a case–control study
Wang, H., Weng, C., & Chen, H. (2017) · Journal of Human Hypertension · doi:10.1038/jhh.2016.97 · Cited by 4
Comparison of the shortened and standard saline infusion tests for primary aldosteronism diagnostics
Yamashita, K., Yatabe, M., Seki, Y., Bokuda, K., Watanabe, D., Shimizu, S., Morimoto, S., & Ichihara, A. (2020) · Hypertension Research · doi:10.1038/s41440-020-0454-9 · Cited by 4
Upregulation of PCP4 in human aldosterone-producing adenomas fosters human adrenocortical tumor cell growth via AKT and AMPK pathway.
Aji, G., Li, F., Chen, J., Leng, F., Hu, K., Cheng, Z., Luo, Y., Xu, X., Zhang, J., & Lu, Z. (2018) · PubMed Central · Cited by 4
Reassessment of Urinary Aldosterone Measurement After Saline Infusion in Primary Aldosteronism
Kaneko, H., Umakoshi, H., Ishihara, Y., Nanba, K., Tsuiki, M., Kusakabe, T., Satoh‐Asahara, N., Yasoda, A., & Tagami, T. (2020) · Journal of the Endocrine Society · doi:10.1210/jendso/bvaa100 · Cited by 4
Associated factors and effects of comorbid atrial fibrillation in hypertensive patients due to primary aldosteronism
Sakaguchi, S., Okamoto, R., Inoue, C., Akao, M., Kamemura, K., Kurihara, I., Takeda, Y., Ohno, Y., Inagaki, N., Rakugi, H., et al. (2022) · Journal of Human Hypertension · doi:10.1038/s41371-022-00753-2 · Cited by 4
Assessment of biochemical outcomes in patients with primary aldosteronism after adrenalectomy based on CT scan diagnosis of unilateral adenoma without adrenal vein sampling
Zhang, M., Bian, G., Tian, J., Yang, W., Wang, X., & Chi, C. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.944035 · Cited by 4
La chirurgie d’épargne surrénalienne : du cortex à la médulla
Ferrière, A., Kerlan, V., & Tabarin, A. (2017) · Annales d Endocrinologie · doi:10.1016/s0003-4266(17)30921-6 · Cited by 4
Altération de la fonction systolique longitudinale du ventricule gauche en strain bidimensionnel dans l’hyperaldostéronisme primaire : un nouveau marqueur d’atteinte d’organe cible
Boulestreau, R., Crémer, A., Delarche, N., & Gosse, P. (2018) · Annales de Cardiologie et d Angéiologie · doi:10.1016/j.ancard.2018.08.007 · Cited by 4
Prediction of long-term biochemical cure in patients with unilateral primary hyperaldosteronism treated surgically based on the early post-operative plasma aldosterone value
Ishihara, Y., Umakoshi, H., Kaneko, H., Nanba, K., Tsuiki, M., Kusakabe, T., Satoh-Asahara, N., Yasoda, A., & Tagami, T. (2021) · Endocrine Journal · doi:10.1507/endocrj.ej21-0430 · Cited by 4
Clinical cure vs a novel trifecta system for evaluating long-term outcomes of minimally-invasive partial or total adrenalectomy for unilateral primary aldosteronism: results of a multicentric series
Anceschi, U., Tufano, A., Flammia, R. S., Mormando, M., Fiori, C., Zappalà, O., CONCILIO, B. D., Carrara, A., Consiglia, F. M., Tuderti, G., et al. (2022) · Editor-in-Chief s Voice List of Authors is an Important Element in a Scientific Publication · doi:10.5173/ceju.2022.147 · Cited by 4
The Evolution of Primary Aldosteronism and the Role of NorrinPreprint
Salle, S. P., Heydarpour, M., Tsai, C., Brown, J. M., Newman, A. J., Mahrokhian, S., Hanna, I., Honzel, B., Tsai, L. C., Waikar, S. S., et al. (2025) · medRxiv · doi:10.1101/2025.06.05.25329066 · Cited by 4
Shifting paradigms in primary aldosteronism: reconsideration of screening strategy via integrating pathophysiological insights
Kitamoto, T., Ruike, Y., Koide, H., Inoue, K., Maezawa, Y., Omura, M., Nakai, K., Tsurutani, Y., Saito, J., Kuwa, K., et al. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1372683 · Cited by 4
Efficacy and Safety of Treatment With Low Doses of Spironolactone in Patients With Primary Aldosteronism: A Retrospective Observational Study in a Tertiary Center
Sconfienza, E., Mallart-Riancho, J., Gebara, N., Ferrão, D., Burrello, J., de Fréminville, J.-B., Deflorenne, E., Lorthioir, A., Azizi, M., & Amar, L. (2026) · Hypertension · doi:10.1161/hypertensionaha.125.24881 · Cited by 4
Self-citation
The outcomes of transcatheter adrenal ablation in patients with primary aldosteronism: a systematic review and meta-analysis
Yang, S., Wang, G., Li, N., & Zhu, Q. (2023) · BMC Endocrine Disorders · doi:10.1186/s12902-023-01356-9 · Cited by 3
Measurement accuracy and cutoffs for predicting primary aldosteronism diagnosis using Lumipulse® for renin and aldosterone measurements
Laney, M., Nabi-Bourgois, A., Mallart-Riancho, J., Travers, S., Chebbi, M., Kling, A., Amar, L., & Baron, S. (2025) · PLoS ONE · doi:10.1371/journal.pone.0319219 · Cited by 3
Self-citation
A Single Initiating Cause of Hypertension; Potential for Primary Prevention
Sambhi, M. P. (2014) · Journal of Hypertension Open Access · doi:10.4172/2167-1095.1000169 · Cited by 3
X-chromosome variants are associated with aldosterone producing adenomas
Dutta, R. K., Larsson, M., Arnesen, T., Heie, A., Walz, M. K., Alesina, P. F., Gimm, O., & Söderkvist, P. (2021) · Scientific Reports · doi:10.1038/s41598-021-89986-8 · Cited by 3
Anatomy and anatomical variations of adrenal veins and its application to adrenal venous sampling
Saadi, A., Bedoui, M. A., Mokadem, S., Zaghbib, S., Boussaffa, H., Bellali, M., Ayed, H., Bouzouita, A., Derouiche, A., Allouche, M., et al. (2024) · Surgical and Radiologic Anatomy · doi:10.1007/s00276-024-03331-y · Cited by 3
Serum aldosterone in right ventricular failure versus left ventricular failure before and after mineralocorticoid receptor antagonists: case-control clinical trial
El-Hefny, N. E. A. M., Mohammed, H. S. E.-D., El-Mahdy, R. I., Haridi, S. H. M., & Mohamed, A. S. (2023) · Acta cardiologica. Supplementum · doi:10.1080/00015385.2023.2266648 · Cited by 3
Utility of Adrenal Vein Sampling With and Without Ultra‐Low Dose ACTH Infusion in the Diagnostic Evaluation of Primary Aldosteronism
Preston, C., Yong, E. X. Z., Marginson, B., Farrell, S., Sawyer, M., Hashimura, H., Derbyshire, M. M., MacIsaac, R. J., & Sachithanandan, N. (2024) · Endocrinology Diabetes & Metabolism · doi:10.1002/edm2.70001 · Cited by 3
A comparative study of postadrenalectomy hyperuricemia and renal impairment in patients with unilateral primary aldosteronism: does histopathology subtype matter?
Fang, C., Hsieh, H.-L., Wang, S., Huang, K., Peng, K., Lin, Y., Wu, V., & Chueh, S. (2024) · BMC Nephrology · doi:10.1186/s12882-024-03750-4 · Cited by 3
Timeline of Advances in Genetics of Primary Aldosteronism
Meyer, L. S., Reincke, M., & Williams, T. A. (2019) · Experientia supplementum · doi:10.1007/978-3-030-25905-1_11 · Cited by 3
The Quality of Clinical Practice Guidelines and Consensuses on the Management of Primary Aldosteronism: A Critical Appraisal
Meng, Z., Zhou, L., Dai, Z., Xu, C., Qian, G., Peng, M., Zhu, Y., Kwong, J. S. W., & Wang, X. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.00136 · Cited by 3
Adrenal BORDeAux reGistry: Bordeaux single-center study of hypertensive patients with primary hyperaldosteronism
Benoit, J., Gaudissard, J., Doublet, J., Boulestreau, R., Robert, G., Brossaud, J., Gosse, P., & Crémer, A. (2022) · Journal of Hypertension · doi:10.1097/hjh.0000000000003091 · Cited by 3
Hyperaldosteronism: How to Discriminate Among Different Disease Forms?
Crudo, V. L., Monticone, S., Burrello, J., Buffolo, F., Tetti, M., Veglio, F., & Mulatero, P. (2016) · High Blood Pressure & Cardiovascular Prevention · doi:10.1007/s40292-016-0151-6 · Cited by 3
Improved Visualization and Identification of the Right Adrenal Vein in 70-kVp Contrast-Enhanced Computed Tomography
Maruyama, K., Sofue, K., Horinouchi, H., Okada, T., Ueshima, E., Gentsu, T., Sasaki, K., Yamaguchi, M., Sugimoto, K., & Murakami, T. (2020) · Journal of Computer Assisted Tomography · doi:10.1097/rct.0000000000000960 · Cited by 3
Parameters of captopril challenge test can predict results of other confirmatory tests for primary aldosteronism and propose the next test to be done
Tamura, N., Yamada, K., Hatakeyama, H., Torii-Hanakita, M., Kyo, C., Kosugi, R., Yonemoto, T., Ogawa, T., Kotani, M., Usui, T., et al. (2020) · Endocrine Journal · doi:10.1507/endocrj.ej19-0498 · Cited by 3
Implementation of a formal sleep center–based screening protocol for primary aldosteronism in patients with obstructive sleep apnea
Wright, K. E., Mahmoudi, M., Agrawal, N., Simpson, H., Lui, M. S., Pachter, H. L., Patel, K. N., Prescott, J. D., & Suh, I. (2022) · Surgery · doi:10.1016/j.surg.2022.05.041 · Cited by 3
Prevalence and impact of diabetes and prediabetes on presentation and complications of primary hyperaldosteronism at diagnosis
Sanyal, D., Mukhopadhyay, P., & Ghosh, S. K. (2024) · World Journal of Clinical Cases · doi:10.12998/wjcc.v12.i18.3332 · Cited by 2
Clinical value of sublingual microcirculatory dysfunction for screening for primary aldosteronism in hypertensive patients
Wang, W., Liu, W., Tang, Y., Sun, F., He, H., Yan, Z., Li, Q., & Zhu, Z. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1561503 · Cited by 2
Primary Aldosteronism: Small Molecule Antagonists of Mutant KCNJ5 Potassium Channels
Mir-Bashiri, S., Tetti, M., Fröbel, D., Pang, Y., Yang, Y., Reiss, D., Bibus, J., Peitzsch, M., Eisenhofer, G., Bechmann, N., et al. (2025) · Hypertension · doi:10.1161/hypertensionaha.125.25360 · Cited by 2
Partially Successful Adrenal Vein Sampling With and Without Cross-Sectional Imaging in Primary Aldosteronism Subtyping
Vibhatavata, P., Mermejo, L. M., Zhao, L., Shields, J. J., & Turcu, A. F. (2025) · Hypertension · doi:10.1161/hypertensionaha.125.26149 · Cited by 2
Clinical manifestations of primary aldosteronism and cardiometabolic risk
Corrales, E. P., Ruiz-Cánovas, J. M., & Peña, M. M. P. (2025) · Vitamins and hormones · doi:10.1016/bs.vh.2025.08.002 · Cited by 2
Pooled diagnostic accuracy of 68Ga-pentixafor PET/CT for aldosterone-producing lesions in primary aldosteronism
Ohannesian, V. A., Rajchenberg, D., Menezes, I. R., Han, M. L., Pereira, K. D. L. A., de Castro, W. C. N., Fagundes, A. F., Motta, R. F. O. S., Neto, M. J. F., Braga, C. A. P., et al. (2026) · Clinical Imaging · doi:10.1016/j.clinimag.2026.110743 · Cited by 2
Treatment of Primary Aldosteronism
Salle, S. P., Hundemer, G. L., Nehs, M. A., Barletta, J. A., & Vaidya, A. (2026) · Hypertension · doi:10.1161/hypertensionaha.126.26238 · Cited by 4
Genetic mechanisms of primary aldosteronism
Fayad, M., Cosentino, T., Faedda, N., Boulkroun, S., Zennaro, M., & Fernandes-Rosa, F. L. (2026) · Annales d Endocrinologie · doi:10.1016/j.ando.2026.102558 · Cited by 2
Curable congestive heart failure in patients with primary aldosteronism: two cases reports.
Chen, Z., Zhang, Z., Xi, Q., Huang, G., & Wang, L. (2022) · PubMed Central · Cited by 2
Anatomical and functional remodeling of left ventricle in patients with primary aldosteronism and concomitant albuminuria
Kao, T., Wu, X.-M., Liao, C., Tsai, C., Chen, Z., Chang, Y., Lee, B., Chiu, Y., Lai, T., Wu, V., et al. (2023) · Therapeutic Advances in Chronic Disease · doi:10.1177/20406223221143253 · Cited by 2
Endocrine hypertension in pregnancy
Jebasingh, F., & Thomas, N. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-96120-2.00004-2 · Cited by 2
Hemorrhage from Adrenal Vein Rupture during Adrenal Vein Sampling
Quencer, K. B., Massouh, A., & Anand, K. (2023) · Seminars in Interventional Radiology · doi:10.1055/s-0043-1769769 · Cited by 2
Prediction of endogenous mineralocorticoid receptor activity by depressor effects of mineralocorticoid receptor antagonists in patients with primary aldosteronism
Ikemoto, M., Morimoto, S., & Ichihara, A. (2024) · Hypertension Research · doi:10.1038/s41440-024-01651-5 · Cited by 2
Impact of the transition from radioimmunoassay (RIA) to chemiluminescent enzyme immunoassay (CLEIA) for the measurement of plasma aldosterone concentration (PAC) on the diagnosis of primary aldosteronism (PA) via retrospective analyses in Okinawa, Japan
Honma, K.-I., Nakayama, Y., Tamaki, A., Uehara, M., Teruya, T., Yabiku, T., Ishiki, Y., Yonaha, K., Chinen, R., Uema, T., et al. (2024) · Endocrine Journal · doi:10.1507/endocrj.ej24-0227 · Cited by 2
Primary Aldosteronism: A Field on the Move
Doumas, M. N., & Δούμα, Σ. (2016) · Updates in hypertension and cardiovascular protection · doi:10.1007/978-3-319-34141-5_2 · Cited by 2
Rational Approach to a Patient with Suspected Primary Aldosteronism
Kocjan, T. (2017) · InTech eBooks · doi:10.5772/66965 · Cited by 2
Systemic Hormonal Unloading in Unilateral Adrenalectomy in a Patient with Bilateral Adrenal Hyperplasia: A Case Report
Gomez, M. F. C., Gan, F. R., Mendoza, E., & MERCADO-ASIS, L. B. (2019) · Journal of Medicine University of Santo Tomas · doi:10.35460/2546-1621.2018-0055 · Cited by 2
A case of primary aldosteronism with resistant hypertension successfully treated by unilateral adrenalectomy after unsuccessful classification of subtype in adrenal venous sampling
Nakamaru, R., Yamamoto, K. I., Nozato, S., Hongyo, K., Nagasawa, M., Hagiya, H., Nakagami, F., Akasaka, H., Kurinami, H., Takami, Y., et al. (2019) · Clinical Case Reports · doi:10.1002/ccr3.2317 · Cited by 2
A case of primary aldosteronism with a negative aldosterone-to-renin ratio
Liu, F., Wang, L., & Ding, Y. (2021) · BMC Cardiovascular Disorders · doi:10.1186/s12872-021-02162-8 · Cited by 2
Difficulty factors of adrenal venous sampling based on patient characteristics and imaging findings
Kumasaka, S., Tokue, H., & Tsushima, Y. (2021) · Acta Radiologica · doi:10.1177/02841851211034046 · Cited by 2
A Case of a Pregnant Woman With Primary Aldosteronism and Superimposed Preeclampsia Treated With Esaxerenone
Yamashita, K., Morimoto, S., Inoue, Y., Hirata, K., Kimura, S., Seki, Y., Bokuda, K., Watanabe, D., & Ichihara, A. (2022) · Journal of the Endocrine Society · doi:10.1210/jendso/bvac085 · Cited by 2
RETRACTED: Validation of the Aldosteronoma Resolution Score as a Predictive Resolution Score of Hypertension After Unilateral Adrenalectomy for Primary Aldosteronism in a North‐African Population
Saadi, A., Bedoui, M. A., Zaghbib, S., Boussaffa, H., Mokaddem, S., Nacef, I. B., Ayed, H., Bouzouita, A., Derouiche, A., Khiari, K., et al. (2023) · World Journal of Surgery · doi:10.1007/s00268-023-07155-6 · Cited by 2
Retracted
Primary Aldosteronism or Not Primary Aldosteronism
Freel, E. M. (2017) · Hypertension · doi:10.1161/hypertensionaha.117.09050 · Cited by 2
Oxidative stress in patients affected by primary aldosteronism
Sambhi, M. P. (2015) · Journal of Hypertension · doi:10.1097/hjh.0000000000000523 · Cited by 2
Primary Aldosteronism
Boulkroun, S., & Zennaro, M. (2023) · Endocrinology · doi:10.1007/978-3-030-44628-4_13-1 · Cited by 1
Successful lateralization by adrenal vein sampling in a patient of primary aldosteronism on concurrent mineralocorticoid receptor antagonist: Time to change the narrative
Jain, R., John, N. T., & Khatana, P. (2024) · Endocrine and Metabolic Science · doi:10.1016/j.endmts.2024.100190 · Cited by 1
Using Point of Care Rapid Cortisol Measurement During Adrenal Venous Sampling in Primary Hyperaldosteronism
Rabani, H., Sheikh‐Ahmad, M., Sachner, R., Yosefia, S., Yeiches, M., Chen‐Konak, L., Henig, C., Dakwar, B., Shalata, A., Jovanovic, K., et al. (2024) · Diagnostics · doi:10.3390/diagnostics14232692 · Cited by 1
The diagnostic utility of the captopril challenge test for primary aldosteronism in a Bangladeshi population: a prospective study
Jahan, S., Lu, Z. X., Akram, M., Hasanat, M. A., Fariduddin, M., Fuller, P. J., & Yang, J. (2025) · Pathology · doi:10.1016/j.pathol.2025.04.003 · Cited by 1
Primary Aldosteronism and Long‐Term Cardiovascular Complications: Comparison of Medical Versus Surgical Treatment
Benameur, S., Bertolino, J., Bonnaud, L., Nguyen, N. A. T., Leclercq, B., Silhol, F., Castinetti, F., Sebag, F., Vaisse, B., & Sarlon-Bartoli, G. (2025) · Journal of Clinical Hypertension · doi:10.1111/jch.70128 · Cited by 1
Peptide Deformylase Regulates Aldosterone Production Through Calbindin 1
Luo, M., Ma, L., Wang, X., Yu, Y., Hu, J., Peng, C., Du, M., Chen, J., Xu, Y., Huang, W., et al. (2025) · Hypertension · doi:10.1161/hypertensionaha.124.24395 · Cited by 1
Testing for Primary Aldosteronism Underutilized Following Stroke: A Multicenter Cohort Study
McCarthy, J., Widjaja, J., Gao, F. M., Lee, I., Lai, J. H., Akram, M., Gupta, S., Choi, P. M. C., Phan, T. G., & Yang, J. (2025) · Stroke · doi:10.1161/strokeaha.125.052691 · Cited by 1
Secondary causes and renal outcomes in apparently resistant hypertension: a retrospective cohort study
Kvapil, T., Kociánová, E., Ramík, Z., Olšr, J., Rada, M., Flašík, J., Modrák, M., Jelínek, L., Mizera, J., & Václavík, J. (2026) · Blood Pressure · doi:10.1080/08037051.2026.2612792 · Cited by 1
Gut microbiota signatures in primary aldosteronism and functional identification of an aldosterone-degrading gut bacterium
Zhang, Z., Chen, C., Zhang, M., Zhu, J., Xu, X., Wang, Z., Zhou, L., Wu, C., Zong, M., Yin, T., et al. (2026) · Gut Microbes · doi:10.1080/19490976.2026.2657047 · Cited by 1
Finerenone: a next-generation nonsteroidal mineralocorticoid receptor antagonist reshaping the management of cardiovascular and metabolic diseases
Zhang, H., Li, M., & Deng, W. (2026) · Biochemical Pharmacology · doi:10.1016/j.bcp.2026.118201 · Cited by 2
Incidental and Intentional Medicine Achieve Similar Results in Primary Hyperaldosteronism
Kuo, L. E. Y., Wachtel, H., Roses, R. E., Fraker, D. L., & Kelz, R. R. (2015) · Annals of Surgical Oncology · doi:10.1245/s10434-015-4729-3 · Cited by 1
Cardiovascular complications in patients with primary hyperaldosteronism
Khokhunov, O. A., Каронова, Т. Л., Tsoy, U. A., & Grineva, E. N. (2017) · Arterial’naya Gipertenziya (Arterial Hypertension) · doi:10.18705/1607-419x-2017-23-3-203-211 · Cited by 2
Manejo anestésico en la cirugía de las glándulas suprarrenales
Schläpfer, P., Albrecht, E., Baumgartner, M., & Blanc, C. (2017) · EMC - Anestesia-Reanimación · doi:10.1016/s1280-4703(17)84134-7 · Cited by 1
Adrenal Secretome and Epicardial Adipose Tissue
Petramala, L., Concistrè, A., Iannucci, G., & Letizia, C. (2020) · Contemporary cardiology · doi:10.1007/978-3-030-40570-0_14 · Cited by 1
Eplerenone Improves Vascular Endothelial Function in Patients with Primary Aldosteronism: A Pilot Study
Kurozumi, A., Okada, Y., & Tanaka, Y. (2021) · Journal of UOEH · doi:10.7888/juoeh.43.379 · Cited by 1
Impact of Endocrine Disorders on Vasculature
Carbone, F., Bonaventura, A., Liberale, L., Vecchié, A., Casula, M., Dallegri, F., & Montecucco, F. (2020) · Endocrinology · doi:10.1007/978-3-319-68729-2_4 · Cited by 1
Do multiple types of confirmatory tests improve performance in predicting subtypes of primary aldosteronism?
Kaneko, H., Umakoshi, H., Fukumoto, T., Wada, N., Ichijo, T., Sakamoto, S., Watanabe, T., Ishihara, Y., Tagami, T., Ogata, M., et al. (2022) · Clinical Endocrinology · doi:10.1111/cen.14854 · Cited by 1
Impact of an endocrine hypertension unit on the diagnosis of primary aldosteronism
Ruiz-Sánchez, J. G., & Meneses, D. (2023) · Endocrinología Diabetes y Nutrición (English ed ) · doi:10.1016/j.endien.2023.05.002 · Cited by 1
Using plasma aldosterone concentrations at 1 h of saline infusion test for the diagnosis of primary aldosteronism
Phonanuwong, R., Jannoo, S., Chanthanuwat, S., & Soonthornpun, S. (2023) · Journal of Hypertension · doi:10.1097/hjh.0000000000003504 · Cited by 1
Prognostic Predictors of Hypertension Outcomes After Adrenalectomy in Primary Aldosteronism
FUKUSHIMA, H., Mitsunari, K., Harada, J., Nakamura, Y., Matsuo, T., Ohba, K., MOCHIZUKI, Y., & IMAMURA, R. (2024) · In Vivo · doi:10.21873/invivo.13751 · Cited by 1
Rating the response of primary aldosteronism to targeted medical treatment with the PAMO criteria
Steichen, O. (2025) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(24)00344-9 · Cited by 1
Self-citation

Authors: Savard, S., Amar, L., Plouin, P.-F., & Steichen, O.
Affiliations: Assistance Publique – Hôpitaux de Paris (FR)
ORCID: Amar, Laurence
Steichen, Olivier
Venue: Hypertension
Publisher: Ovid Technologies (Wolters Kluwer Health)
Published: 2013-08
Volume: 62
Issue: 2
Pages: 331-336
ISSN: 0194-911X (ISSN-L)
1524-4563
DOI: 10.1161/hypertensionaha.113.01060
OpenAlex: W2168924012
Cited by: 505
References: 50
Citations by year: 2026: 24 · 2025: 34 · 2024: 37 · 2023: 39 · 2022: 48 · 2021: 46 · 2020: 41 · 2019: 43 · 2018: 38 · 2017: 47 · 2016: 32 · 2015: 37 · 2014: 29 · 2013: 10
FWCI: 28.37
Type: journal article
Language: en
Open access: closed
Locations: Hypertension (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Renin-Angiotensin System Studies
Health Sciences › Medicine › Nephrology › Potassium and Related Disorders
Keywords: primary aldosteronism, cardiovascular complications, essential hypertension, left ventricular hypertrophy, coronary artery disease, myocardial infarction, heart failure, atrial fibrillation, aldosterone-renin ratio, serum potassium, plasma aldosterone, target organ damage
MeSH terms: Adult, Cardiovascular Diseases, Cross-Sectional Studies, Female, Humans, Hyperaldosteronism, Hypertension, Male, Middle Aged, Hypertrophy, Left Ventricular

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Cardiovascular Complications Associated With Primary Aldosteronism: A Controlled Cross-Sectional Study

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks